Search
for
Sort by
Research 121–150 of 1000+
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- Vitamina D y la piel. Una revisión para dermatólogos
- Androgen- and Estrogen-Secreting Adrenal Cancers
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Huge Proliferating Trichilemmal Tumors of the Scalp: Report of Six Cases
- Drug safety evaluation of exemestane
- Feminizing Adrenocortical Carcinoma Without Gynecomastia
- Models for Skin Cancer
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- JAAD Grand Rounds quiz∗
- Cutaneous adverse effects of targeted therapies
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Review of Scalp Alopecia due to a Clinically Unapparent or Minimally Apparent Neoplasm (SACUMAN)
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Protein Kinase C Epsilon Signals Ultraviolet Light‐induced Cutaneous Damage and Development of Squamous Cell Carcinoma Possibly Through Induction of Specific Cytokines in a Paracrine Mechanism<sup>¶</sup>
- Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
- Immunotherapy-Induced Scarring Alopecia: A Case Series
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Editorial: Androgen-dependent diseases and their treatment
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Epithelial‐to‐mesenchymal transition in cutaneous wound healing: Where we are and where we are heading
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Scalp melanoma: Distinctive high risk clinical and histological features
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling